Target Healthcare REIT PLC Admission, share capital and total voting rights (0162O)
27 Settembre 2019 - 4:45PM
UK Regulatory
TIDMTHRL
RNS Number : 0162O
Target Healthcare REIT PLC
27 September 2019
Target Healthcare REIT plc
Admission, share capital and total voting rights
Following the announcement on 26 September 2019, 72,398,191 new
ordinary shares will be admitted to the premium segment of the
official list of the Financial Conduct Authority ("FCA") and to
trading on the main market of the London Stock Exchange with effect
from 8.00 a.m. on Monday 30 September ("Admission").
As explained in the Prospectus published by the Company on 21
June 2019, the Company applied to the High Court of England and
Wales (the "Court") to reduce the nominal value of its ordinary
shares from GBP1.00 to GBP0.01 per ordinary share (the
"Reduction"). The Directors are pleased to announce that the Court
has confirmed the Reduction and the Court's order has been
registered by the Registrar of Companies. The Reduction is
effective and the Company's issued share capital therefore,
following the Reduction and Admission, will consist of 457,487,640
ordinary shares of GBP0.01 each. The total number of voting rights
of the Company will be 457,487,640 and this figure may be used by
shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or
a change to their interest in, the share capital of the Company
under the FCA's Disclosure Guidance and Transparency Rules.
For information purposes, the trading details in relation to the
Company's ordinary shares are as follows:
TIDM: THRL
ISIN: GB00BJGTLF51
SEDOL: BJGTLF5
LEI: 213800RXPY9WULUSBC04
Enquiries:
Target Fund Managers Limited (Investment Manager to the
Company)
Kenneth MacKenzie +44 1786 845 912
Gordon Bland +44 1786 845 920
Stifel Nicolaus Europe Limited
Mark Young mark.young@stifel.com +44 20 7710 7600
Tom Yeadon tom.yeadon@stifel.com +44 20 7710 7600
Neil Winward neil.winward@stifel.com +44 20 7710 7600
FTI Consulting TargetHealthcare@fticonsulting.com +44 20 3727 1000
Dido Laurimore
Claire Turvey
Richard Gotla
Notes:
A copy of this announcement will be available on the Company's
website.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCBSGDCXSDBGCR
(END) Dow Jones Newswires
September 27, 2019 10:45 ET (14:45 GMT)
Grafico Azioni Target Healthcare Reit (LSE:THRL)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Target Healthcare Reit (LSE:THRL)
Storico
Da Apr 2023 a Apr 2024